Robinson Pharma, Inc. is pleased to announce of its newest building acquisitions.
SANTA ANA, Calif., February 16, 2022 (Newswire.com) – Robinson Pharma, Inc. (“RPI”) is pleased to announce two of its newest building acquisitions.
These new Santa Ana, California facilities will bring Robinson Pharma Inc. to nine state-of-the-art buildings to date, totaling over 1 million square feet combined. The newly acquired buildings will provide support to fuel RPI’s continuing business growth.
About Robinson Pharma, Inc.
Robinson Pharma, Inc., (RPI) is a Southern California-based full-service contract manufacturer of dietary supplements with over 1 million square feet of combined warehouse and production capabilities of capsules, softgels, gummies, tablets, powders, and liquids. Robinson Pharma, Inc. possesses multiple third-party certifications of current Good Manufacturing Practice (cGMP), and Safe Quality Food (SQF) compliance from well-reputed organizations such as NSF, UL, and Eurofins for supplement manufacturing in the United States.
We understand your unique challenges as a business growing in the health/nutrition industry, and we believe that your success is our success. Come grow with us!
Contact us today to learn more about our new offerings.
E-mail [email protected], Tel. 714-241-0235 ext. 1214, or at www.robinsonpharma.com
